SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001410939-23-000041
Filing Date
2023-04-05
Accepted
2023-04-05 16:11:23
Documents
18
Period of Report
2023-03-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2023def14a-proxystatement.htm DEF 14A 1378353
2 a03sjbb_ivericxbioxcommonxb.jpg GRAPHIC 1020512
3 a03sjbb_ivericxbioxcommonxc.jpg GRAPHIC 349533
4 a1-comppaidvstsra.gif GRAPHIC 47146
5 a2023_bodxskillsmatrixa.jpg GRAPHIC 235802
6 a3biotechindexa.gif GRAPHIC 21232
7 aba.jpg GRAPHIC 3901
8 aga.jpg GRAPHIC 3861
9 atriskpaya.gif GRAPHIC 37967
10 corporatenarrativea.jpg GRAPHIC 82752
11 cra.jpg GRAPHIC 5417
12 drdugela.jpg GRAPHIC 16849
13 gsa.jpg GRAPHIC 5506
14 ivericlogoa.jpg GRAPHIC 11159
15 jha.jpg GRAPHIC 4817
16 mba.jpg GRAPHIC 4137
17 nigrapha.jpg GRAPHIC 65393
18 picture5a.jpg GRAPHIC 14501
  Complete submission text file 0001410939-23-000041.txt   4033457
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36080 | Film No.: 23802654
SIC: 2834 Pharmaceutical Preparations